In rats, EA exerted anti-inflammatory and antioxidant functions against streptozotocin -induced diabetic nephropathy via reducing the activation of NF-κB and increasing the nuclear translocation of Nrf2 to up-regulate the activities of GSH, γ-GCL and SOD [18]. Here, SOD1 is linked to diabetic kidney disease.